Pipobroman: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Pipobroman.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Pipobroman.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Pipobroman''' (trade names '''Vercite''', '''Vercyte''') is an anti-cancer drug that probably acts as an [[alkylating antineoplastic agent|alkylating agent]]. | '''Pipobroman''' (trade names '''Vercite''', '''Vercyte''') is an anti-cancer drug that probably acts as an [[alkylating antineoplastic agent|alkylating agent]]. | ||
==References== | ==References== | ||
| Line 16: | Line 12: | ||
{{Chemotherapeutic agents}} | {{Chemotherapeutic agents}} | ||
[[Category:Organobromides]] | [[Category:Organobromides]] | ||
[[Category:Amides]] | [[Category:Amides]] | ||
[[Category:Piperazines]] | [[Category:Piperazines]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 17:34, 7 April 2015
|
WikiDoc Resources for Pipobroman |
|
Articles |
|---|
|
Most recent articles on Pipobroman |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pipobroman at Clinical Trials.gov Clinical Trials on Pipobroman at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pipobroman
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pipobroman Discussion groups on Pipobroman Patient Handouts on Pipobroman Directions to Hospitals Treating Pipobroman Risk calculators and risk factors for Pipobroman
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pipobroman |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.